Webinar · United Kingdom
Eclevar UK’s first webinar on the UKCA mark and future regulations.
Eclevar UK’s inaugural webinar brought together experts from across the sector to debate the UKCA mark, the MHRA’s consultation response and what it means for UK MedTech and IVD.
Eclevar UK were pleased to announce their first webinar in a series around the UKCA mark and the future regulations, held on 20 July 2022 at 11am BST. This inaugural session hosted a discussion between confirmed panel representatives from BSI, ABHI, BIVDA and FIND.
An informed, honest debate
The panel brought together a wealth of experience in medical device and IVD regulation across both the UK and EU markets. At a critical moment for the UK, the session examined the MHRA’s recent consultation response and what it means for the UK MedTech and IVD sector, from the perspective of industry and an Approved Body, with honest and differing opinions.
Preparing for UKCA marking?
Talk to Eclevar MedTech about UKCA, MHRA and UK clinical investigation strategy.
Book a free scoping call